Biblio
“The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S567-S610, 2018.
, “Amyloid-β Reduces Exosome Release from Astrocytes by Enhancing JNK Phosphorylation.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1433-41, 2016.
, “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
, “Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based Assays.”, J Alzheimers Dis, vol. 64, no. s1, pp. S659-S672, 2018.
, “Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction.”, J Alzheimers Dis, vol. 66, no. 2, pp. 789-799, 2018.
, “Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.”, J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
, “Analysis of Brain Donors' Demographic and Medical Characteristics to Facilitate the Construction of a Human Brain Bank in China.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1245-1254, 2018.
, “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
, “Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 997-1004, 2020.
, “Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.”, J Alzheimers Dis, 2015.
, “Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
, “Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1237-1254, 2017.
, “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
, “Anemia in Association with Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 72, no. 3, pp. 803-814, 2019.
, “Anesthesia/Surgery Induces Cognitive Impairment in Female Alzheimer's Disease Transgenic Mice.”, J Alzheimers Dis, vol. 57, no. 2, pp. 505-518, 2017.
, “Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 75, no. 2, pp. 521-529, 2020.
, “Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology.”, J Alzheimers Dis, vol. 58, no. 1, pp. 203-214, 2017.
, “Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus.”, J Alzheimers Dis, vol. 77, no. 2, pp. 543-545, 2020.
, “Ankle-Brachial Index but Neither Intima Media Thickness Nor Coronary Artery Calcification is Associated With Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 2, pp. 433-42, 2015.
, “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
, “Anomalous White Matter Structure and the Effect of Age in Down Syndrome Patients.”, J Alzheimers Dis, vol. 57, no. 1, pp. 61-70, 2017.
, “Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
, “Anterior Cingulate Structure and Perfusion Is Associated with Cerebrospinal Fluid Tau Among Cognitively Normal Older Adult APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 73, no. 1, pp. 87-101, 2020.
, “Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State.”, J Alzheimers Dis, vol. 50, no. 4, pp. 981-98, 2016.
, “Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.”, Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
,